Faye M. Johnson

7.2k total citations
150 papers, 4.4k citations indexed

About

Faye M. Johnson is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Faye M. Johnson has authored 150 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 61 papers in Molecular Biology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Faye M. Johnson's work include Head and Neck Cancer Studies (37 papers), Lung Cancer Treatments and Mutations (31 papers) and Lung Cancer Research Studies (21 papers). Faye M. Johnson is often cited by papers focused on Head and Neck Cancer Studies (37 papers), Lung Cancer Treatments and Mutations (31 papers) and Lung Cancer Research Studies (21 papers). Faye M. Johnson collaborates with scholars based in United States, United Kingdom and China. Faye M. Johnson's co-authors include Banibrata Sen, Babita Saigal, Ignacio I. Wistuba, Nicholas J. Donato, Stephen Y. Lai, Gary E. Gallick, Moshe Talpaz, Bonnie S. Glisson, Shaohua Peng and J. Jack Lee and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Faye M. Johnson

147 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Faye M. Johnson United States	41	2.2k	2.1k	1.0k	629	532	150	4.4k
Raanan Berger Israel	34	2.2k 1.0×	4.2k 2.0×	1.9k 1.9×	1.2k 1.9×	429 0.8×	160	7.2k
Jin S. Lee United States	30	1.3k 0.6×	1.2k 0.6×	960 0.9×	466 0.7×	488 0.9×	60	3.4k
Hidayatullah G. Munshi United States	45	2.3k 1.1×	2.5k 1.2×	482 0.5×	1.1k 1.8×	116 0.2×	106	4.8k
Edgar Selzer Austria	35	1.7k 0.8×	951 0.5×	360 0.3×	525 0.8×	414 0.8×	106	3.7k
Michele Del Vecchio Italy	34	1.9k 0.9×	3.6k 1.7×	993 1.0×	316 0.5×	261 0.5×	169	5.1k
Anthony M. Magliocco Canada	38	1.3k 0.6×	1.8k 0.9×	1.1k 1.0×	853 1.4×	144 0.3×	136	4.2k
Ravindra Uppaluri United States	36	1.5k 0.7×	3.0k 1.4×	785 0.8×	716 1.1×	659 1.2×	100	5.2k
Jianping Xiong China	36	2.1k 1.0×	2.0k 0.9×	1.6k 1.6×	1.3k 2.0×	140 0.3×	189	5.0k
Ann‐Joy Cheng Taiwan	44	2.6k 1.2×	1.2k 0.6×	574 0.6×	1.3k 2.0×	1.3k 2.5×	121	5.1k
Dongfeng Tan United States	37	1.9k 0.9×	1.6k 0.8×	901 0.9×	897 1.4×	116 0.2×	124	4.0k

Countries citing papers authored by Faye M. Johnson

Since Specialization

Citations

This map shows the geographic impact of Faye M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faye M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faye M. Johnson more than expected).

Fields of papers citing papers by Faye M. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faye M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faye M. Johnson. The network helps show where Faye M. Johnson may publish in the future.

Co-authorship network of co-authors of Faye M. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Faye M. Johnson. A scholar is included among the top collaborators of Faye M. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faye M. Johnson. Faye M. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carlander, Amanda‐Louise Fenger, Simone K. Bendtsen, Jacob H. Rasmussen, et al.. (2024). Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas. European Journal of Cancer. 202. 113983–113983. 4 indexed citations

Moreno, Amy C., Yun Qing, J. Jack Lee, et al.. (2024). Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry Analysis. Otolaryngology. 170(5). 1319–1330. 3 indexed citations

McGrail, Daniel J., Kaiyi Li, Faye M. Johnson, et al.. (2024). Neoadjuvant immunotherapy for oropharynx cancer: Correlative studies and long-term outcomes from the CIAO trial.. Journal of Clinical Oncology. 42(16_suppl). 6059–6059. 1 indexed citations

Ghosh, Soma, Tuhina Mazumdar, Wei Xu, et al.. (2022). Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus–Driven Cancers. Clinical Cancer Research. 28(20). 4479–4493. 13 indexed citations

Guo, Theresa, Christopher M. K. L. Yao, Kimberley L. Kiong, et al.. (2021). Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation. Cancer. 127(16). 2916–2925. 7 indexed citations

Dahlstrom, Kristina R., Juhee Song, Peter F. Thall, et al.. (2020). Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis. Cancer. 127(8). 1228–1237. 3 indexed citations

Sambandam, Vaishnavi, Mitchell J. Frederick, Li Shen, et al.. (2019). PDK1 Mediates NOTCH1 -Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition. Clinical Cancer Research. 25(11). 3329–3340. 42 indexed citations

Gay, Carl M., Pan Tong, Robert J. Cardnell, et al.. (2018). Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers. Clinical Cancer Research. 25(1). 346–357. 12 indexed citations

Zhang, Jiexin, Li Shen, Xiayu Rao, et al.. (2017). CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition. Cancer Research. 78(3). 781–797. 34 indexed citations

10.

Min, Hye‐Young, Su-Chan Lee, Jong Kyu Woo, et al.. (2016). Essential Role of DNA Methyltransferase 1–mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors. Clinical Cancer Research. 23(5). 1299–1311. 21 indexed citations

11.

Danilov, Alexey V., Shanhu Hu, Bernardo Orr, et al.. (2016). Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2. Molecular Cancer Therapeutics. 15(11). 2758–2766. 36 indexed citations

12.

Tanaka, Noriaki, Ameeta A. Patel, Jiping Wang, et al.. (2015). Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins. Clinical Cancer Research. 21(21). 4831–4844. 46 indexed citations

13.

Ferrarotto, Renata, Suk Young Yoo, Pan Tong, et al.. (2015). Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer. Clinical Cancer Research. 22(7). 1674–1686. 40 indexed citations

14.

Jones, Robin L., Edward S. Kim, Pilar Nava-Parada, et al.. (2014). Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors. Clinical Cancer Research. 21(4). 693–700. 77 indexed citations

15.

Mazumdar, Tuhina, Lauren A. Byers, Patrick Kwok Shing Ng, et al.. (2014). A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 13(11). 2738–2750. 66 indexed citations

16.

Saintigny, Pierre, Shaohua Peng, Li Zhang, et al.. (2012). Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and Invasion. Molecular Cancer Therapeutics. 11(9). 2021–2032. 48 indexed citations

17.

Sen, Banibrata, Shaohua Peng, Denise M. Woods, et al.. (2011). STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma. Clinical Cancer Research. 18(1). 127–139. 53 indexed citations

18.

Sen, Banibrata, Shaohua Peng, Babita Saigal, Michelle D. Williams, & Faye M. Johnson. (2010). Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c-Src Inhibition in Head and Neck Cancer. Clinical Cancer Research. 17(3). 514–524. 45 indexed citations

19.

Saintigny, Pierre, Sufi M. Thomas, Adel K. El‐Naggar, et al.. (2010). Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral Cancer. Cancer Prevention Research. 3(7). 800–809. 88 indexed citations

20.

Sen, Banibrata, Babita Saigal, Nila U. Parikh, Gary E. Gallick, & Faye M. Johnson. (2009). Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase–STAT3 Binding. Cancer Research. 69(5). 1958–1965. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact